Business Case

Provided transaction advisory for potential acquisition of new therapy treatment technology for global MedTech company​

Through in-depth primary research, developed view of the investment attractiveness of new therapy treatment technology. Determined the effectiveness of new therapy including its clinical endpoints, the applicable settings of care, and the competitor pipeline. Developed revenue forecast based on adoption and pricing potential ​